Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Glenmark Arzneimittel GmbH
Medicines register · Ireland

Glenmark Arzneimittel GmbH — licensed medicines

20 medicines held by Glenmark Arzneimittel GmbH on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
20 of 10,295 medicines
Download
Medicine
Active substance
Licence holder
Status
Apremilast Glenmark 10 mg + 20 mg + 30 mg film-coated tablets PA22645/007/001
Apremilast, Apremilast, Apremilast
Glenmark Arzneimittel GmbH
Not marketed
Apremilast Glenmark 30mg film-coated tablets PA22645/007/002
Apremilast
Glenmark Arzneimittel GmbH
Not marketed
Atovaquone/Proguanil Hydrochloride 250 mg /100 mg film-coated tablets PA22645/006/001
Atovaquone, PROGUANIL HYDROCHLORIDE
Glenmark Arzneimittel GmbH
Not marketed
Desloratadine Glenmark 5 mg tablets PA22645/004/001
Desloratadine
Glenmark Arzneimittel GmbH
Not marketed
Escitalopram Glenmark 10 mg film-coated tablets PA22645/005/002
Escitalopram
Glenmark Arzneimittel GmbH
Not marketed
Escitalopram Glenmark 15 mg film-coated tablets PA22645/005/003
Escitalopram
Glenmark Arzneimittel GmbH
Not marketed
Escitalopram Glenmark 20 mg film-coated tablets PA22645/005/004
Escitalopram
Glenmark Arzneimittel GmbH
Not marketed
Escitalopram Glenmark 5 mg film-coated tablets PA22645/005/001
Escitalopram
Glenmark Arzneimittel GmbH
Not marketed
Levocetirizine Glenmark 5 mg Film-coated Tablets PA22645/003/001
Levocetirizine dihydrochloride
Glenmark Arzneimittel GmbH
Not marketed
Nebivolol 10mg tablets PA22645/002/001
Nebivolol hydrochloride
Glenmark Arzneimittel GmbH
Not marketed
Olanzapine Glenmark 10 mg tablets EU/1/09/587/10-12
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark 15 mg tablets EU/1/09/587/13-15
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark 2.5 mg tablets EU/1/09/587/1-3
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark 20 mg tablets EU/1/09/587/16-17
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark 5 mg tablets EU/1/09/587/4-6
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark 7.5 mg tablets EU/1/09/587/7-9
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark Europe 10 mg orodispersible tablets EU/1/09/588/4-6
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark Europe 15 mg orodispersible tablets EU/1/09/588/7-9
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark Europe 20 mg orodispersible tablets EU/1/09/588/10-12
Olanzapine
Glenmark Arzneimittel GmbH
—
Olanzapine Glenmark Europe 5 mg orodispersible tablets EU/1/09/588/1-3
Olanzapine
Glenmark Arzneimittel GmbH
—
Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/glenmark-arzneimittel-gmbh

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.